Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 5 of 5

TitleReference numberPublishedLast updated
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Axxent electronic brachytherapy system for early stage breast cancerMIB76
Breast cancerQS12

Results per page

  1. 10
  2. 25
  3. 50
  4. All